Genetic Technologies Ltd ADR (NASDAQ:GENE)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - GENE

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - GENE

  • Market Cap$62.870m
  • SymbolNASDAQ:GENE
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINUS37185R3075

Company Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.Genetic Technologies Ltd is a molecular diagnostics company which offers predictive testing and assessment tools to help physicians manage women’s health. It has developed BREVAGenplus, which is a is a clinically validated risk assessment test.

Latest GENE news

Currently there for this company. Visit our news hub for other news .